These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19945449)

  • 1. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.
    Rios DR; Carvalho Md; Lwaleed BA; Simões e Silva AC; Borges KB; Dusse LM
    Clin Chim Acta; 2010 Feb; 411(3-4):135-9. PubMed ID: 19945449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
    Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
    Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular effects of hemodialysis in chronic kidney disease.
    Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.
    Karacan O; Tutal E; Colak T; Sezer S; Eyüboğlu FO; Haberal M
    Transplant Proc; 2006 Mar; 38(2):396-400. PubMed ID: 16549130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
    Puskar D; Pasini J; Savić I; Bedalov G; Sonicki Z
    Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep vein thrombosis in end-stage renal disease.
    Ifudu O; Delaney VB; Barth RH; Friedman EA
    ASAIO J; 1994; 40(1):103-5. PubMed ID: 8186484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dysfunction in renal failure.
    Boccardo P; Remuzzi G; Galbusera M
    Semin Thromb Hemost; 2004 Oct; 30(5):579-89. PubMed ID: 15497100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure].
    Brzósko S; Hryszko T; Zak J; Wysocka J; Małyszko J; Myśliwiec M
    Przegl Lek; 2002; 59(10):823-5. PubMed ID: 12632921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of arterial compliance in patients treated by hemodialysis.
    Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
    Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of hemostasis in chronic renal failure and renal transplantation].
    Goluza E; Topalović MG; Hudolin T; Konosić S; Kocman IB; Perić M
    Acta Med Croatica; 2011; 65(4):337-47. PubMed ID: 22359906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and clinical implications of microbubbles during hemodialysis.
    Barak M; Nakhoul F; Katz Y
    Semin Dial; 2008; 21(3):232-8. PubMed ID: 18363602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients.
    ElChoufani SE; Bolin P; Waien S; Christiano CR; Holbert D; Bode AP
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):399-409. PubMed ID: 18160614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of platelet aggregation in patients with end-stage renal disease.
    Martinović Z; Basić-Jukić N; Pavlović DB; Kes P
    Acta Clin Croat; 2013 Dec; 52(4):472-7. PubMed ID: 24696998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
    Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
    Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.